Search - tctmd.com

Displaying 101 - 120 of 169

Sort: Relevancy | Date

Off Script: As the Quantification of Cath Lab Quality Gets an Upgrade, Frustrations Abound

News Opinion Off Script ACC 2019

Off Script: As the Quantification of Cath Lab Quality Gets an Upgrade, Frustrations Abound

March 17, 2019

TCTMD’s Top 10 Most Popular Stories for February 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

March 01, 2019

Femoral Operators Get Bad Rap in Observational Studies, HEAT-PPCI Suggests

News Daily News

Femoral Operators Get Bad Rap in Observational Studies, HEAT-PPCI Suggests

Michael O'Riordan

January 21, 2019

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

News Daily News

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

December 11, 2018

Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients

News Conference News AHA 2018

Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients

November 11, 2018

Study Lays Groundwork for Pivotal Trial of Impella CP for LV Unloading Before PCI

News Conference News AHA 2018

Study Lays Groundwork for Pivotal Trial of Impella CP for LV Unloading Before PCI

November 11, 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

November 05, 2018

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

July 30, 2018

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

May 02, 2018

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

News Daily News

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

April 12, 2018

News Industry News

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

April 05, 2018

Impella Heart Pumps Get Expanded Indication for Cardiogenic Shock in Setting of Cardiomyopathy

News Daily News

Impella Heart Pumps Get Expanded Indication for Cardiogenic Shock in Setting of Cardiomyopathy

February 13, 2018

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

News Daily News

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

October 02, 2017

Nirmanmoh Bhatia, MD

News Featured Fellow

Nirmanmoh Bhatia, MD

Yael L. Maxwell

July 11, 2017

News Industry News

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

May 05, 2017

Prioritizing Impella Support May Boost Cardiogenic Shock Survival, Pilot Study Suggests

News Conference News ACC 2017

Prioritizing Impella Support May Boost Cardiogenic Shock Survival, Pilot Study Suggests

March 22, 2017

TCT 1162: Impella 5.0 Fracture And Transcatheter Retrieval

Presentation TCT 2016

TCT 1162: Impella 5.0 Fracture And Transcatheter Retrieval

Presenter: William A. Gray, Issam D. Moussa, Moses Mathur

October 30, 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

October 29, 2016

News Industry News

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

September 27, 2016

News Daily News

Mortality Risk High in TAVR Patients Who Require Mechanical Circulatory Support

August 25, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.